Is it time yet for intravitreal triamcinolone to be used in routine clinical practice?
Gillies
Mark
M
D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005938:Glucocorticoids / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007267:Injections; D012164:Retinal Diseases / Q000188:drug therapy; D012449:Safety; D014222:Triamcinolone Acetonide / Q000009:adverse effects / Q000627:therapeutic use*; D014822:Vitreous Body
D005938:Glucocorticoids; D014222:Triamcinolone Acetonide